Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vista Pharmaceuticals Ltd has announced the closure of its trading window for dealing in company securities starting 1st April 2026. The window will remain shut until 48 hours after the Board declares the audited financial results for the quarter and year ending 31st March 2026. This is a standard compliance measure under SEBI's Prohibition of Insider Trading Regulations, restricting designated employees, directors, officers, and their immediate relatives from trading during this period. The date of the Board Meeting to approve the audited FY26 results will be intimated later.
No direct impact on shareholders as this is a routine regulatory filing. However, the closure signals that audited FY26 results are imminent, which could act as a potential catalyst for the stock once announced.